Benchmarking of QSAR models for blood-brain barrier permeation

被引:67
|
作者
Konovalov, Dmitry A. [1 ]
Coomans, Danny
Deconinck, Eric
Vander Heyden, Yvan
机构
[1] James Cook Univ N Queensland, Sch Math Phys & Informat Technol, Townsville, Qld, Australia
[2] Vrije Univ Brussels, Inst Pharmaceut, Dept Analyt Chem & Pharmaceut Technol, Brussels, Belgium
关键词
D O I
10.1021/ci700100f
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Using the largest available database of 328 blood-brain distribution (logBB) values, a quantitative benchmark was proposed to allow for a consistent comparison of the predictive accuracy of current and future logBB/quantitative structure-activity relationship (-QSAR) models. The usefulness of the benchmark was illustrated by comparing the global and k-nearest neighbors (kNN) multiple-linear regression (MLR) models based on the linear free-energy relationship (LFER) descriptors, and one non-LFER-based MLR model. The leave-one-out (LOO) and leave-group-out Monte Carlo (MC) cross-validation results (q(2) = 0.766, qms = 0.290, and qms(mc) = 0.311) indicated that the LFER-based kNN-MLR model was currently one of the most accurate predictive logBB-QSAR models. The LOO, MC, and kNN-MLR methods have been implemented in the QSAR-BENCH program, which is freely available from www.dmitrykonovalov.org for academic use.
引用
收藏
页码:1648 / 1656
页数:9
相关论文
共 50 条
  • [1] QSAR Studies on Blood-Brain Barrier Permeation
    Luco, Juan M.
    Marchevsky, Eduardo
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2006, 2 (01) : 31 - 55
  • [2] QSAR model for blood-brain barrier permeation
    Toropov, Andrey A.
    Toropova, Alla P.
    Beeg, Marten
    Gobbi, Marco
    Salmona, Mario
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2017, 88 : 7 - 18
  • [3] Models for predicting blood-brain barrier permeation
    Nielsen, Peter Aadal
    Andersson, Olga
    Hansen, Steen Honore
    Simonsen, Klaus Baek
    Andersson, Gunnar
    DRUG DISCOVERY TODAY, 2011, 16 (11-12) : 472 - 475
  • [4] Biological models to study blood-brain barrier permeation
    Krämer, SD
    Abbott, NJ
    Begley, DJ
    PHARMACOKINETIC OPTIMIZATION IN DRUG RESEARCH: BIOLOGICAL, PHYSICOCHEMICAL, AND COMPUTATIONAL STRATEGIES, 2001, : 127 - 153
  • [5] In silico prediction models for blood-brain barrier permeation
    Ecker, GF
    Noe, CR
    CURRENT MEDICINAL CHEMISTRY, 2004, 11 (12) : 1617 - 1628
  • [6] Development of QSAR models to predict blood-brain barrier permeability
    Faramarzi, Sadegh
    Kim, Marlene T. T.
    Volpe, Donna A. A.
    Cross, Kevin P. P.
    Chakravarti, Suman
    Stavitskaya, Lidiya
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [7] Novel models for assessing blood-brain barrier drug permeation
    Geldenhuys, Werner J.
    Allen, David D.
    Bloomquist, Jeffrey R.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2012, 8 (06) : 647 - 653
  • [8] Benchmarking in vitro tissue-engineered blood-brain barrier models
    DeStefano, Jackson G.
    Jamieson, John J.
    Linville, Raleigh M.
    Searson, Peter C.
    FLUIDS AND BARRIERS OF THE CNS, 2018, 15
  • [9] The application of in situ and in vitro models for screening blood-brain barrier permeation
    Read, KD
    JOURNAL OF NEUROCHEMISTRY, 2003, 85 : 7 - 7
  • [10] Computational models to predict blood-brain barrier permeation and CNS activity
    Subramanian, G
    Kitchen, DB
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2003, 17 (10) : 643 - 664